Table 3.

Standardized compounded medication commonly prescribed for rare diseases

Compounded Medication	Information Source
Beta-Carotene 30 mg & 100 mg capsules	TMF
Cafeine without citrate 1% 10 ml injection	OpenAPO
Cafëine-citraat 20 mg/2 ml injection	BP, FNA, IJPC
Chenodeoxycholic acid 250 mg capsules	TMF
Ciclosporin 2% eye drops	IJPC
Cysteamine 0,15% & 0,5% eye drops	DAC, FFP
Glycopyrrolate 0,5 mg/ml oral suspension	CT, Fagron, IJPC, IWK, NZ
Hydroxocobalamine 0,1% 10 ml injection	BP, OpenAPO
Levo-Arginine HCl 100 mg/ml 50 ml injection	FNA
Levo-Arginine HCl 100 mg/ml oral liquid	TMF
Levo-Carnitine 200 mg/ml oral liquid	CT, TMF
Midazolam 0,5% nasal spray	FFP
Midazolam 2,5% nasal spray	OpenAPO
Penicillamine 50 mg/ml oral suspension	Fagron
Polihexanide 0,02% eye drops	OpenAPO
Potassium−/sodiumcitrate oral liquid	FNA (prep), IJPC
Potio Joulie (disodium hydrogenphosphate) oral liquid	HUG, IJPC
Primaquine phosphate 30 mg capsules	TMF
Primaquine phosphate 6 mg/5 ml oral suspension	MPA
Propranolol 1 mg/ml oral suspension	Fagron, FFP, IJPC, IWK, SEFH
Propranolol 5 mg/ml oral suspension	CHEO, FPP, NZ
Pyridoxal phosphate 10 mg capsules	TMF
Pyridoxal phosphate 25 mg/ml oral suspension	NC
Riboflavin 10 mg/ml oral suspension	CRI, Fagron
Sildenafil Citrate 2,5 mg/ml oral suspension	CHEO, IWK, MPA, NZ, SEFH, USP40
Sodium benzoate 100 mg/ml oral liquid	TMF
Sodium dihydrogen phosphate 156 mg/ml oral liquid	CT, FNA
Sodium phenylbutyrate 200 mg/ml oral liquid	IJCP, TMF, USP40
Sodium thiosulphate injection	BP
Ursodeoxycholic acid suspension 15 mg/ml oral suspension	FFP
Ursodeoxycholic acid suspension 20 mg/ml oral suspension	IWK, MPA, NC
Ursodeoxycholic acid suspension 50 mg/ml oral suspension	CHEO, CRI, NZ, USP40